نتایج جستجو برای: oncolysis

تعداد نتایج: 455  

Journal: :Journal of virology 2008
Dror Kolodkin-Gal Gideon Zamir Yair Edden Eli Pikarsky Alon Pikarsky Hillel Haim Yosef S Haviv Amos Panet

Viral therapy of cancer (viral oncolysis) is dependent on selective destruction of the tumor tissue compared with healthy tissues. Several factors, including receptor expression, extracellular components, and intracellular mechanisms, may influence viral oncolysis. In the present work, we studied the potential oncolytic activity of herpes simplex virus type 1 (HSV-1), using an organ culture sys...

Journal: :Clinical cancer research : an official journal of the American Association for Cancer Research 2005
Jianfeng Zhou Qinglei Gao Gang Chen Xiaoyuan Huang Yunping Lu Kanyan Li Daxing Xie Liang Zhuang Jingniu Deng Ding Ma

PURPOSE Polo-like kinase 1 (plk1) is a serine/threonine protein kinase essential for multiple mitotic processes. Previous observations have validated plk1 as a promising therapeutic target. Despite being conceptually attractive, the potency and specificity of current plk1-based therapies remain limited. We sought to develop a novel plk1-targeting strategy by constructing an oncolytic adenovirus...

2015
Otto Hemminki Suvi Parviainen Juuso Juhila Riku Turkki Nina Linder Johan Lundin Matti Kankainen Ari Ristimäki Anniina Koski Ilkka Liikanen Minna Oksanen Dirk M. Nettelbeck Kalevi Kairemo Kaarina Partanen Timo Joensuu Anna Kanerva Akseli Hemminki

Oncolytic viruses that selectively replicate in tumor cells can be used for treatment of cancer. Accumulating data suggests that virus induced oncolysis can enhance anti-tumor immunity and break immune tolerance. To capitalize on the immunogenic nature of oncolysis, we generated a quadruple modified oncolytic adenovirus expressing granulocyte-macrophage colony-stimulating factor (GMCSF). Ad5/3-...

2014
Jun Gong Monica M. Mita

The development of wild-type, unmodified Type 3 Dearing strain reovirus as an anticancer agent has currently expanded to 32 clinical trials (both completed and ongoing) involving reovirus in the treatment of cancer. It has been more than 30 years since the potential of reovirus as an anticancer agent was first identified in studies that demonstrated the preferential replication of reovirus in t...

2014
Lynne Braidwood Kirsty Learmonth Alex Graham Joe Conner

Oncolytic herpes simplex virus (HSV1716), lacking the neurovirulence factor ICP34.5, has highly selective replication competence for cancer cells and has been used in clinical studies of glioma, melanoma, head and neck squamous cell carcinoma, pediatric non-central nervous system solid tumors, and malignant pleural mesothelioma. To date, 88 patients have received HSV1716 and the virus is well t...

2014
Gang Meng Mao Xia Diancheng Wang Aiping Chen Yongshan Wang Hongwei Wang Decai Yu Jiwu Wei

Apoptosis contributes to antitumor effect of Newcastle disease virus (NDV). Autophagy is a protective response under cellular stress including viral infection. How autophagy interferes with oncolysis of NDV remains unclear. In this study, we found that NDV La Sota strain induced autophagy and preserved autophagic flux in non-small cell lung cancer cells. NDV-induced autophagy promoted viral rep...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید